Connect Biopharma Holdings annual current ratio
2021
2022
2023
2024
2025
Connect Biopharma Holdings Current Ratio Growth & History (CNTB)
Connect Biopharma Holdings's current ratio was 3.74 for fiscal 2025.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 3.74 | −7.72 | −67.35% |
| 2024 | 2024-12-31 | 11.46 | 6.61 | +136.48% |
| 2023 | 2023-12-31 | 4.85 | −5.13 | −51.40% |
| 2022 | 2022-12-31 | 9.97 | −5.33 | −34.82% |
| 2021 | 2021-12-31 | 15.30 | — | — |
Connect Biopharma Holdings quarterly current ratio
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.37 | −4.87 | −67.27% |
| Q1 2026 | 2026-03-31 | 3.23 | −7.02 | −68.50% |
| Q4 2025 | 2025-12-31 | 3.74 | −7.72 | −67.35% |
| Q3 2025 | 2025-09-30 | 5.48 | — | — |
| Q2 2025 | 2025-06-30 | 7.24 | −4.80 | −39.89% |
| Q1 2025 | 2025-03-31 | 10.25 | — | — |
| Q4 2024 | 2024-12-31 | 11.46 | 6.61 | +136.48% |
| Q2 2024 | 2024-06-30 | 12.04 | 2.79 | +30.12% |
| Q4 2023 | 2023-12-31 | 4.85 | −5.13 | −51.40% |
| Q2 2023 | 2023-06-30 | 9.25 | −0.32 | −3.37% |
| Q4 2022 | 2022-12-31 | 9.97 | — | — |
| Q2 2022 | 2022-06-30 | 9.58 | — | — |
Connect Biopharma Holdings current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Connect Biopharma Holdings's current ratio decreased from 15.30 to 3.74, a change of −11.56. The latest reported quarter, Q2 2026, shows 2.37.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Connect Biopharma Holdings source filings ↗